Chen and colleagues showed that BAG3 mRNA levels were significantly higher in CLL than in healthy controls, with BAG3 levels in the drug-resistant group higher, as compared with the drug-responsive group [100]. Here, BAG3 is linked to B-cell chronic lymphocytic leukemia.